信息搜索
信息关键字：药
  

共有4715条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236]

·优卡丹被曝含损儿童肝肾有毒物 药店可轻松买到2013-1-23 16:13:24
·太龙药业：年报预增 扩张产能求发展2013-1-23 14:08:13
·20年专利已去8年 信邦制药人参皂苷_Rd仍在“审批中”2013-1-23 12:53:04
·合作方肝癌药“揭盲”在即 海正药业强化经销权2013-1-23 12:48:49
·弃羚锐制药增发 两机构错失巨额浮盈2013-1-23 12:40:29
·云南白药拟逾1亿元收购云南药物研究所全部股权2013-1-23 11:41:59
·华邦制药与加拿大YES合作 研制治疗银屑病新药2013-1-23 9:07:26
·美国克莱瑞恩和浙江海正达成药物开发协议_亚洲经济2013-1-23 8:55:09
·广药加多宝渠道战火升级王老吉试水直销不被看好2013-1-23 8:50:40
·上海医药：内部波动逐步消除 聚焦主业2013-1-23 8:37:53
·联邦制药陷“污水门”2013-1-23 8:25:47
·弃羚锐制药增发 两机构错失巨额浮盈2013-1-23 5:31:55
·华邦制药携手加企进军生物制药领域2013-1-23 5:10:58
·华邦制药拟联手加企研发银屑病新药2013-1-22 22:13:16
·云南白药拟逾1亿元收购控股股东旗下药物所全部股权2013-1-22 21:14:46
·科伦药业:公司未来将大力发展非输液业务2013-1-22 18:27:38
·太龙药业年报预增 扩张产能求发展2013-1-22 17:37:35
·莱美药业拟披露重大事项 午后继续停牌2013-1-22 13:56:20
·信邦制药主打药保护期将满 避谈风险被指信披遗漏2013-1-22 12:45:16
·大病医保升级为医药行业带来增长新动力2013-1-22 7:12:04

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236]